USPTO serial 99897042
Reviewed by CopyMark Law Group
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Seongnam-si, Gyeonggi-do, Seoul, KR
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick J. Concannon
Patrick J. Concannon Nutter, McClennen & Fish, LLPSeaport West, 155 Seaport BoulevardBoston, MA 02210United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations for suppressing tumors; Vaccines; Vaccine preparations; Pharmaceutical products for the prevention and treatment of cancer; Anti-cancer preparations; Pharmaceutical preparations for the treatment of viral diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer; Biological preparations for the prevention and treatment of cancer; Pharmaceutical preparations, namely, antivirals | ACTIVE | — |
| 042 | Pharmaceutical research and development; Research and development of pharmaceutical preparations for treating malignant tumours; Technical research in the field of pharmaceutical studies; Development of pharmaceutical preparations and medicines; Scientific research for medical purposes in the field of cancerous diseases; Medical research; Providing scientific research information in the field of pharmaceuticals; Scientific study and research in the field(s) of medicine; Research and development services in the field of medical preparations; Research and development of new products in the field of pharmaceuticals | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 22, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 22, 2026 | NWAP | NEW APPLICATION ENTERED | — |